Ursprung des Netzwerks ersten Grades von Hisako Otoshi
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Editforce, Inc.
Editforce, Inc. Miscellaneous Commercial ServicesCommercial Services Editforce, Inc. engages in research, development and production of medicinal drugs. The company is headquartered in Fukuoka, Japan.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hisako Otoshi
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | Investment Managers | Private Equity Investor | |
bitBiome, Inc.
bitBiome, Inc. Miscellaneous Commercial ServicesCommercial Services The Japanese company has a wealth of experience in micro-biome research and have obtained high-quality microbial genome data from various samples. The company is based in Tokyo, Japan. The company strategically combines their own single-cell analysis technology, bit-map®, to realize the next-generation microbiome analysis that approaches the essence of microbial functions. The company also uses the microbial genomic information owned by bitBiome to provide new knowledge for research and development promoted by joint partners and customers. The company was founded by Yoshihito Daimon, Masahito Hosokawa. Kimihiko Sato has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
MiRTeL Co. Ltd.
MiRTeL Co. Ltd. Miscellaneous Commercial ServicesCommercial Services MiRTeL Co. Ltd. engages in the business of gene testing services. Its services include research and development of health diagnostic systems; clinical examination and health related materials to medical care; sale of medical devices; clinical testing and clinical diagnostic services; planning of medical and information systems related to clinical testing; manufacturing, sale, import and export of pharmaceutical products and health foods; collection and delivery of reagents, containers and materials; manufacture and sale of DNA measuring kits; and all types of businesses related to clinical laboratories. The company was founded on September 3, 2012 and is headquartered in Hiroshima, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
ITOCHU Technology Ventures, Inc.
ITOCHU Technology Ventures, Inc. Investment ManagersFinance ITOCHU Technology Ventures, Inc. (Itochu Technology Ventures) is a venture capital arm of ITOCHU Corp. headquartered in Tokyo, Japan. The firm was founded in 2000 by ITOCHU Corp. | Investment Managers | Private Equity Investor | |
LeapMind, Inc.
LeapMind, Inc. Packaged SoftwareTechnology Services LeapMind, Inc. is a holding company that develops photo analysis technology. Its products include Black Star, Monolith, Deep Insight, and Ingrid. The company was founded by Soichi Matsuda on December 25, 2012 and is headquartered in Tokyo, Japan. | Packaged Software | Director/Board Member | |
ITOCHU CORPORATION | Food Distributors | Corporate Officer/Principal | |
Osaka University | College/University | Graduate Degree | |
SOLASIA PHARMA K.K. | Pharmaceuticals: Major | Director/Board Member | |
Kisco Ltd.
Kisco Ltd. Pharmaceuticals: MajorHealth Technology KISCO Ltd. manufactures and supplies industrial chemicals, equipment, and processed goods. Its chemicals segment manufactures fat and fragrance-related compounds, organic and inorganic compounds, intermediates for pharmaceuticals and toiletries, additives, catalysts, inhibitors, and reagents. The company was founded in 1921 and is headquartered in Osaka, Japan. | Pharmaceuticals: Major | Director/Board Member | |
Newton Biocapital Partners /Japan/ | Private Equity Investor | ||
RIBOMIC INC. | Pharmaceuticals: Major | Director/Board Member | |
J-Pharma Co., Ltd.
J-Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology J-Pharma Co. Ltd. develops pharmaceutical products. It develops therapeutics and diagnostic agents for treatment of cancer. The company was founded in 2005 and is headquartered in Yokohama, Japan. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Japan | 13 |
Sektoral
Health Technology | 5 |
Finance | 3 |
Commercial Services | 3 |
Technology Services | 2 |
Distribution Services | 2 |
Operativ
Director/Board Member | 15 |
Private Equity Investor | 3 |
Corporate Officer/Principal | 3 |
Graduate Degree | 1 |
Chief Executive Officer | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Koji Abe | 6 |
Atsushi Usami | 4 |
Toshiyuki Mori | 3 |
Teruyuki Fukuda | 2 |
Yao Li | 2 |
Takashi Ono | 1 |
Yusuke Yagi | 1 |
Satoru Nakanishi | 1 |
- Börse
- Insiders
- Hisako Otoshi
- Unternehmensverbindungen